Mepenzolate is a post-ganglionic parasympathetic inhibitor. It decreases gastric acid and pepsin secretion and suppresses spontaneous contractions of the colon. Mepenzolate diminishes gastric acid and pepsin secretion. Mepenzolate also suppresses spontaneous contractions of the colon. Pharmacologically, it is a post-ganglionic parasympathetic inhibitor. It has not been shown to be effective in contributing to the healing of peptic ulcer, decreasing the rate of recurrence, or preventing complications. It is grouped under the following drug class(es): Anticholinergics. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Mepenzolic acid and Mepenzolate cation. Its PubChem CID is 4057.
Mepenzolate
| CAS No | 25990-43-6 |
|---|---|
| Molecular Formula | C21H26NO3+ |
| Molecular Weight | 340.40 g/mol |
| Synonyms | (1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenylacetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mepenzolate is a post-ganglionic parasympathetic inhibitor. It decreases gastric acid and pepsin secretion and suppresses spontaneous contractions of the colon.
The listed CAS number is 25990-43-6.
The listed molecular formula is C21H26NO3+.
The listed molecular weight is 340.40 g/mol.
(1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenylacetate.
The source lists Mepenzolic acid and Mepenzolate cation.